Oncologist and Patient Preferences for Novel Agents in First-Line Treatment for Chronic Lymphocytic Leukemia: Commonalities and Disconnects

Autor: Le H, Ryan K, Wahlstrom SK, Maculaitis MC, Will O, Mulvihill E, LeBlanc TW

Publikováno v: Patient Preference and Adherence, Vol Volume 15, Pp 99-110 (2021)

Hannah Le,1 Kellie Ryan,1 Svea K Wahlstrom,2 Martine C Maculaitis,3 Oliver Will,4 Emily Mulvihill,5 Thomas W LeBlanc6 1US Medical Affairs, AstraZeneca, Gaithersburg, MD, USA; 2US Patient Safety, AstraZeneca, Wilmington, DE, USA; 3Kantar, Health Divis

Externí odkaz: https://doaj.org/article/b485c072dbad4411b7ae989b2144f26c

Polypharmacy in patients with advanced cancer and the role of medication discontinuation

Autor: LeBlanc, TW, McNeil, MJ, Kamal, AH, Currow, DC, Abernethy, AP

© 2015 Elsevier Ltd. Polypharmacy is a well known problem in elderly patients in general, but its prevalence and effects in patients with cancer are less clear, particularly in end-of-life settings. This Review examines the existing literature on po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::9895fabe5817280346eadb7a2d011809
https://hdl.handle.net/10453/118604

What is the role of friends when contributing care at the end of life? Findings from an Australian population study

Autor: Burns, CM, Abernethy, AP, Leblanc, TW, Currow, DC

Purpose: To examine the role of friends as caregivers of people with terminal illness. Method: Piloted questions were included in the 2001-2007 random face-to-face annual health surveys of 23â588 South Australians on the death of a loved one, caregi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::4a3b9ba59fc920dc8b4164f0c669e266
https://hdl.handle.net/10453/118239

Symptom experience of patients undergoing treatment for multiple myeloma: a longitudinal real-world electronic patient-reported outcomes study.

Autor: Patel MN; Duke University School of Medicine, Durham, NC, USA., Nina A; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA., Branchaud B; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA., Herring KW; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA., Johnson S; Carevive Systems, Inc., Boston, MA, USA., Scott J; Carevive Systems, Inc., Boston, MA, USA., LeBlanc TW; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. thomas.leblanc@duke.edu.; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA. thomas.leblanc@duke.edu.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Nov 18; Vol. 32 (12), pp. 802. Date of Electronic Publication: 2024 Nov 18.

Timing of Palliative Care Consultation Impacts End of Life Care Outcomes in Metastatic Non-Small Cell Lung Cancer.

Autor: Oswalt CJ; Duke Cancer Institute (C.J.O., S.C.L., T.W.L.B.,), Durham, North Carolina, USA. Electronic address: cameron.oswalt@duke.edu., Nakatani MM; Medicine-Psychiatry Resident (M.M.N.), Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Troy J; Department of Biostatistics and Bioinformatics (J.T., S.W.), Division of Biostatistics, Duke University School of Medicine, Durham, North Carolina, USA., Wolf S; Department of Biostatistics and Bioinformatics (J.T., S.W.), Division of Biostatistics, Duke University School of Medicine, Durham, North Carolina, USA., Locke SC; Duke Cancer Institute (C.J.O., S.C.L., T.W.L.B.,), Durham, North Carolina, USA., LeBlanc TW; Duke Cancer Institute (C.J.O., S.C.L., T.W.L.B.,), Durham, North Carolina, USA.

Publikováno v: Journal of pain and symptom management [J Pain Symptom Manage] 2024 Oct; Vol. 68 (4), pp. e325-e332. Date of Electronic Publication: 2024 Jul 24.